263 related articles for article (PubMed ID: 35149998)
1. The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).
Reckweg JT; Uthaug MV; Szabo A; Davis AK; Lancelotta R; Mason NL; Ramaekers JG
J Neurochem; 2022 Jul; 162(1):128-146. PubMed ID: 35149998
[TBL] [Abstract][Full Text] [Related]
2. The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action.
Tap SC
Addict Biol; 2024 Apr; 29(4):e13386. PubMed ID: 38600715
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.
Halberstadt AL
Pharmacol Biochem Behav; 2016 Apr; 143():1-10. PubMed ID: 26780349
[TBL] [Abstract][Full Text] [Related]
4. "In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E.coli".
Friedberg LM; Sen AK; Nguyen Q; Tonucci GP; Hellwarth EB; Gibbons WJ; Jones JA
Metab Eng; 2023 Jul; 78():61-71. PubMed ID: 37230161
[TBL] [Abstract][Full Text] [Related]
5. 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice.
Jefferson SJ; Gregg I; Dibbs M; Liao C; Wu H; Davoudian PA; Woodburn SC; Wehrle PH; Sprouse JS; Sherwood AM; Kaye AP; Pittenger C; Kwan AC
Neuropsychopharmacology; 2023 Aug; 48(9):1257-1266. PubMed ID: 37015972
[TBL] [Abstract][Full Text] [Related]
6. Molecular Docking, MM-GBSA, and Molecular Dynamics Approach: 5-MeO-DMT Analogues as Potential Antidepressants.
Kalirajan R; Rishabh K; Srikanth J; Niharika M; Preeya N; Rezaul I
Arch Razi Inst; 2023 Oct; 78(5):1603-1614. PubMed ID: 38590677
[TBL] [Abstract][Full Text] [Related]
7. Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-
Rucker JJ; Roberts C; Seynaeve M; Young AH; Suttle B; Yamamoto T; Ermakova AO; Dunbar F; Wiegand F
J Psychopharmacol; 2024 Apr; ():2698811241246857. PubMed ID: 38616411
[TBL] [Abstract][Full Text] [Related]
8. Structural pharmacology and therapeutic potential of 5-methoxytryptamines.
Warren AL; Lankri D; Cunningham MJ; Serrano IC; Parise LF; Kruegel AC; Duggan P; Zilberg G; Capper MJ; Havel V; Russo SJ; Sames D; Wacker D
Nature; 2024 Jun; 630(8015):237-246. PubMed ID: 38720072
[TBL] [Abstract][Full Text] [Related]
9. 5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study.
Ragnhildstveit A; Khan R; Seli P; Bass LC; August RJ; Kaiyo M; Barr N; Jackson LK; Gaffrey MS; Barsuglia JP; Averill LA
Front Psychiatry; 2023; 14():1271152. PubMed ID: 38076677
[TBL] [Abstract][Full Text] [Related]
10. Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in Mexico.
Davis AK; Xin Y; Sepeda N; Averill LA
Am J Drug Alcohol Abuse; 2023 Sep; 49(5):587-596. PubMed ID: 37734158
[No Abstract] [Full Text] [Related]
11. 5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?
Dourron HM; Nichols CD; Simonsson O; Bradley M; Carhart-Harris R; Hendricks PS
Psychopharmacology (Berl); 2023 Dec; ():. PubMed ID: 38072874
[TBL] [Abstract][Full Text] [Related]
12. 5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats.
Souza AC; Souza BC; França A; Moradi M; Souza NC; Leão KE; Tort ABL; Leão RN; Lopes-Dos-Santos V; Ribeiro S
Sci Rep; 2024 May; 14(1):11281. PubMed ID: 38760450
[TBL] [Abstract][Full Text] [Related]
13. Drug-drug interactions involving classic psychedelics: A systematic review.
Halman A; Kong G; Sarris J; Perkins D
J Psychopharmacol; 2024 Jan; 38(1):3-18. PubMed ID: 37982394
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.
Falchi-Carvalho M; Wießner I; Silva SRB; O Maia L; Barros H; Laborde S; Arichelle F; Tullman S; Silva-Costa N; Assunção A; Almeida R; Pantrigo ÉJ; Bolcont R; Costa-Macedo JV; Arcoverde E; Galvão-Coelho N; Araujo DB; Palhano-Fontes F
Eur Neuropsychopharmacol; 2024 Mar; 80():27-35. PubMed ID: 38141403
[TBL] [Abstract][Full Text] [Related]
15. Psychological and physiological effects of extended DMT.
Luan LX; Eckernäs E; Ashton M; Rosas FE; Uthaug MV; Bartha A; Jagger S; Gascon-Perai K; Gomes L; Nutt DJ; Erritzøe D; Carhart-Harris RL; Timmermann C
J Psychopharmacol; 2024 Jan; 38(1):56-67. PubMed ID: 37897244
[TBL] [Abstract][Full Text] [Related]
16. Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience.
Lawrence DW; Carhart-Harris R; Griffiths R; Timmermann C
Sci Rep; 2022 May; 12(1):8562. PubMed ID: 35610230
[TBL] [Abstract][Full Text] [Related]
17. Novel extended-release transdermal formulations of the psychedelic N,N-dimethyltryptamine (DMT).
Witowski CG; Hess MR; Jones NT; Pellitteri Hahn MC; Razidlo J; Bhavsar R; Beer C; Gonzalez-Velazquez N; Scarlett CO; Wenthur CJ; von Salm JL
Eur J Pharm Sci; 2024 Aug; 199():106803. PubMed ID: 38788435
[TBL] [Abstract][Full Text] [Related]
18. Chronic, Intermittent Microdoses of the Psychedelic
Cameron LP; Benson CJ; DeFelice BC; Fiehn O; Olson DE
ACS Chem Neurosci; 2019 Jul; 10(7):3261-3270. PubMed ID: 30829033
[TBL] [Abstract][Full Text] [Related]
19. Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans.
Barman R; Kumar Bora P; Saikia J; Konwar P; Sarkar A; Kemprai P; Proteem Saikia S; Haldar S; Slater A; Banik D
Phytochemistry; 2024 Feb; 218():113928. PubMed ID: 38035973
[TBL] [Abstract][Full Text] [Related]
20. Rewarding Effects of the Hallucinogen 4-AcO-DMT Administration and Withdrawal in Rats: A Challenge to the Opponent-Process Theory.
Vargas-Perez H; Minauro-Sanmiguel F; Ting-A-Kee R; Grieder TE; Méndez-Díaz M; Prospéro-García O; van der Kooy D
Neurosci Lett; 2024 Jan; 820():137597. PubMed ID: 38110146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
